Xin Su | Infectious Diseases | Best Researcher Award

Published on by Infectious

Dr. Xin Su | Infectious Diseases | Best Researcher Award

Attending Physician | Nanjing University | China

Professor Xin Su, M.D., Ph.D., is a distinguished clinical scientist and Chief Physician renowned for his pioneering contributions to respiratory and critical care medicine, with particular expertise in the study and management of severe pulmonary infections. Over a distinguished career spanning nearly three decades, he has demonstrated an exceptional ability to bridge clinical excellence with translational research innovation. His work focuses on the pathogenesis, diagnosis, and treatment of invasive pulmonary aspergillosis (IPA) in non-neutropenic patients, a challenging and underexplored domain of pulmonary medicine. As a leading investigator, Professor Su has spearheaded multicenter studies that have transformed the understanding of pulmonary fungal infections, combining rigorous clinical observation with the use of novel diagnostic technologies, including machine learning and metagenomic sequencing. His publications in high-impact journals such as The Lancet Infectious Diseases, Microbiology Spectrum, Frontiers in Cellular and Infection Microbiology, and Clinical Microbiology and Infection reflect a deep commitment to advancing evidence-based practices and diagnostic accuracy in the field. Through his groundbreaking studies, Professor Su has introduced innovative diagnostic models that integrate big data analytics with clinical biomarkers, offering more precise and timely identification of IPA and related fungal diseases. Beyond diagnostics, his investigations into host immune responses, interferon signaling, and biomarker development have opened new avenues for prognostic assessment and personalized treatment strategies. His leadership roles as a Chief Physician, Professor, and Doctoral Supervisor at Nanjing University-affiliated hospitals underscore his dual impact as both a clinician and academic mentor. Colleagues and collaborators recognize his unique ability to unite global expertise, as evidenced by his participation in international research consortia addressing fungal infections and severe pneumonia outcomes. His scholarly rigor, coupled with his mentorship of young clinicians and researchers, has significantly enriched the field of respiratory and infectious disease research. While Professor Su’s scientific achievements are substantial, he continues to identify strategic growth areas that align with the evolving challenges of respiratory medicine. Expanding the clinical utility of machine learning-based diagnostic platforms, validating novel biomarkers in diverse patient populations, and enhancing global collaborative networks remain key objectives. Moreover, strengthening translational pathways that connect molecular diagnostics to frontline patient care is an ongoing priority, ensuring that innovations in the laboratory translate into improved clinical outcomes. Looking ahead, Professor Su’s future research aims to deepen the mechanistic understanding of host-pathogen interactions in fungal and viral co-infections, refine AI-driven diagnostic algorithms for pulmonary infections, and integrate multi-omics data into clinical decision-making frameworks. His vision is to establish an internationally recognized precision-medicine model for diagnosing and managing severe respiratory infections, ultimately contributing to reduced mortality, optimized therapeutic strategies, and global health resilience in the era of emerging respiratory pathogens. He has 2677 citations from 128 documents with an h-index of 28.

Profiles: Scopus | ORCID

Publications

1. Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis. (2025). Microbiology Spectrum.

2. Rapid and accurate diagnosis of severe pneumonia: Similarities and differences between severe community-acquired pneumonia and hospital-acquired pneumonia/ventilator-associated pneumonia. (2025). Chinese Journal of Tuberculosis and Respiratory Diseases.

3. Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: A multicenter cohort study. (2025). Microbiology Spectrum.

4. Expert consensus on cancer treatment-related lung injury. (2025). Journal of Thoracic Disease.

5. Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients. (2025). Microbiology Spectrum.

Dr. Abeni Beshiru | Microbiology | Best Academic Researcher Award

Published on by Infectious

Dr. Abeni Beshiru | Microbiology | Best Academic Researcher Award

Western Delta University | Nigeria.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Dr. Abeni Beshiru began her academic journey with a B.Sc. in Microbiology, laying the foundation for her fascination with microbial systems and public health. She pursued her postgraduate studies with a strong commitment to infectious diseases and foodborne pathogens, eventually earning her Ph.D. in Microbiology, where her thesis focused on the microbial quality of food and antimicrobial resistance—a subject that continues to define her research trajectory.

💼PROFESSIONAL ENDEAVORS

With a career marked by dedication and excellence, Dr. Beshiru has held numerous academic and research appointments. She has contributed to several university-based laboratories and national health initiatives, focusing on microbial risk assessments, environmental microbiology, and food safety research. Her interdisciplinary approach bridges microbiology with public health, making her an indispensable asset in both academic and clinical microbiology circles.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON MICROBIOLOGY

Dr. Beshiru’s research spans critical areas in environmental and food microbiology, including antibiotic-resistant bacteria, foodborne pathogens, and the microbiological integrity of food processing environments. She has also explored the dynamics of microbial communities in response to environmental stressors. Her pioneering studies have shed light on Listeria monocytogenes, Salmonella spp., and multi-drug resistant enteric bacteria in consumer foods.

🌍IMPACT AND INFLUENCE

Dr. Beshiru’s work has had a global impact, influencing food safety policies and microbial risk assessment frameworks. Her publications have informed policy briefs and food regulatory standards, particularly in developing countries, where her research addresses pressing issues of sanitation, safe food handling, and emerging pathogens. She is often sought after as a consultant and collaborator in multinational projects.

🏆RESEARCH GRANTS AND FUNDING

Dr. Beshiru has been the recipient of competitive research grants, including funding from national research councils and international organizations supporting projects in foodborne disease surveillance, bacterial resistance profiling, and community-based microbial education. These grants underscore the trust and investment in her scientific leadership and innovation.

🦠LEGACY AND FUTURE CONTRIBUTIONS

She is committed to mentoring early-career researchers, encouraging innovation in microbiological diagnostics, and promoting data-driven approaches to public health microbiology. Her legacy includes student mentorship, laboratory capacity-building, and published toolkits for microbiological analysis. Her future goals focus on combating antimicrobial resistance through genomic surveillance and predictive modeling.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Abeni Beshiru stands out as a visionary leader in the field of infectious disease microbiology, particularly in the context of global health challenges. Her foresight, scientific acumen, and collaborative spirit position her as a key figure in shaping the next generation of microbial threat response strategies.

📑NOTABLE PUBLICATIONS